4//SEC Filing
Genesis Biopharma, Inc 4
Accession 0001513160-13-000042
$IOVACIK 0001425205operating
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 7:17 PM ET
Size
5.6 KB
Accession
0001513160-13-000042
Insider Transaction Report
Form 4
VOYTICKY DAVID J
Director
Transactions
- Award
Common Stock
2013-07-24+13,353,215→ 13,353,215 total(indirect: By Matrix Group International, Inc.)
Holdings
- 5,627,867
Common Stock
Footnotes (2)
- [F1]Common Stock was granted as consideration for services rendered as a Director. The Common Stock was valued at $0.03 per share.
- [F2]Mr. Voyticky is Chairman of Matrix Group International, Inc. and accordingly exercises voting and/or investment control over the shares held by Matrix Group International, Inc.
Documents
Issuer
Genesis Biopharma, Inc
CIK 0001425205
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001425205
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 7:17 PM ET
- Size
- 5.6 KB